<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38761171</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1464-3553</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Chemical senses</Title><ISOAbbreviation>Chem Senses</ISOAbbreviation></Journal><ArticleTitle>Integrating the patient's voice into the research agenda for treatment of chemosensory disorders.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">bjae020</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/chemse/bjae020</ELocationID><Abstract><AbstractText>World-wide some 658 million people were infected with coronavirus disease 2019 (COVID-19) and millions suffer from chemosensory impairment associated with long COVID. Current treatments for taste and smell disorders are limited. Involving patients has the potential to catalyze the dynamic exchange and development of new ideas and approaches to facilitate biomedical research and therapeutics. We assessed patients' perceptions of the efficacy of treatments for chemosensory impairment using an online questionnaire completed by 5,815 people in the US Logistic regression determined variables predictive of reported treatment efficacy for patients aged 18 to 24, 25 to 39, 40 to 60, and 60+ yrs. who were treated with nasal steroids, oral steroids, zinc, nasal rinse, smell training, theophylline, platelet-rich plasma, and Omega 3. The most consistent predictor was age, with the majority of those 40 to 60 and 60+ reporting that nasal steroids, oral steroids, zinc, nasal rinse, and smell training were only slightly effective or not effective at all. Many of these treatment strategies target regeneration and immune response, processes compromised by age. Only those under 40 reported more than slight efficacy of steroids or smell training. Findings emphasize the need to include patients of all ages in clinical trials. Older adults with olfactory impairment are at increased risk for Alzheimer's disease (AD). We speculate that olfactory impairment associated with long COVID introduces the potential for a significant rise in AD. Long COVID-associated chemosensory impairment increases the urgency for translational and clinical research on novel treatment strategies. Suggestions for high-priority areas for epidemiological, basic, and clinical research on chemosensory impairment follow.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6364-8646</Identifier><AffiliationInfo><Affiliation>Department of Psychology,&#xa0;San Diego State University, San Diego, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry,&#xa0;University of California, San Diego, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalton</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2474-2888</Identifier><AffiliationInfo><Affiliation>Monell Chemical Senses Center, Philadelphia, A, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boateng</LastName><ForeName>Katie</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0004-6590-0541</Identifier><AffiliationInfo><Affiliation>The Smell and Taste Association of North America, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2540-7929</Identifier><AffiliationInfo><Affiliation>Monell Chemical Senses Center, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silberman</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0002-9031-8604</Identifier><AffiliationInfo><Affiliation>The Smell and Taste Association of North America, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trachtman</LastName><ForeName>Jenifer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0006-0974-8586</Identifier><AffiliationInfo><Affiliation>Monell Chemical Senses Center, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrandt</LastName><ForeName>Suz</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1648-9595</Identifier><AffiliationInfo><Affiliation>ExPPect, LLC, Arlington, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naimi</LastName><ForeName>Bita</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7679-0908</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology and Neurological Surgery,&#xa0;Thomas Jefferson University, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garvey</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2497-4232</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology and Neurological Surgery,&#xa0;Thomas Jefferson University, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Paule V</ForeName><Initials>PV</Initials><Identifier Source="ORCID">0000-0002-1198-9622</Identifier><AffiliationInfo><Affiliation>Division of Intramural Research,&#xa0;National Institute of Alcohol Abuse and Alcoholism, Section of Sensory Science and Metabolism and National Institute of Nursing Research, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Conner</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2365-9962</Identifier><AffiliationInfo><Affiliation>Department of Psychology,&#xa0;San Diego State University, San Diego, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry,&#xa0;University of California, San Diego, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albertazzi</LastName><ForeName>Abigail</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0000-9349-8923</Identifier><AffiliationInfo><Affiliation>Department of Psychology,&#xa0;San Diego State University, San Diego, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyquist</LastName><ForeName>Gurston</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0000-2905-7789</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology and Neurological Surgery,&#xa0;Thomas Jefferson University, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawson</LastName><ForeName>Nancy E</ForeName><Initials>NE</Initials><Identifier Source="ORCID">0000-0002-7074-3999</Identifier><AffiliationInfo><Affiliation>Monell Chemical Senses Center, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 DC020658</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062006</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG062006-05</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Chem Senses</MedlineTA><NlmUniqueID>8217190</NlmUniqueID><ISSNLinking>0379-864X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013651" MajorTopicYN="N">Taste Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chemosensory disorders</Keyword><Keyword MajorTopicYN="N">patient engagement</Keyword><Keyword MajorTopicYN="N">post-acute COVID</Keyword><Keyword MajorTopicYN="N">research agenda</Keyword><Keyword MajorTopicYN="N">smell</Keyword></KeywordList><CoiStatement>The authors have no conflicts to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>6</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>18</Day><Hour>19</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>18</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38761171</ArticleId><ArticleId IdType="pmc">PMC11154145</ArticleId><ArticleId IdType="doi">10.1093/chemse/bjae020</ArticleId><ArticleId IdType="pii">7676373</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, et al.. At the interface of sensory and motor dysfunctions and Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dementia. 2015:11(1):70&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287457</ArticleId><ArticleId IdType="pubmed">25022540</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander TH, Davidson TM.. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope. 2006:116(2):217&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">16467707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansari KA, Johnson A.. Olfactory function in patients with Parkinson&#x2019;s disease. J Chronic Dis. 1975:28:493&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">1176578</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchamp LC, Finkelstein DI, Bush AL, Evans AH, Barnham KJ.. Parkinsonism as a third wave of the COVID-19 pandemic? J Parkinsons Dis. 2020:10:1343&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683045</ArticleId><ArticleId IdType="pubmed">32986683</ArticleId></ArticleIdList></Reference><Reference><Citation>Benninger MS, Hadley JA, Osguthorpe JD, Marple BF, Leopold DA, Derebery MJ, Hannley M.. Techniques of intranasal steroid use. Otolaryngol Head Neck Surg. 2004:130:5&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">14726906</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesveldt S, Postma EM, Boak D, Welge-Luessen A, Sch&#xf6;pf V, Mainland JD, Martens J, Ngai J, Duffy VB.. Anosmia&#x2014;a clinical review. Chem Senses. 2017:42(7):513&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863566</ArticleId><ArticleId IdType="pubmed">28531300</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Hummel T, Invitto S, Spinato G, Tomasoni M, Emanuelli E, Tofanelli M, Cavicchia A, Grill V, Vaira LA, et al.. Psychophysical assessment of olfactory and gustatory function in post-mild COVID-19 patients: A matched case-control study with 2-year follow-up. Int Forum Allergy Rhinol. 2023:10:1864&#x2013;1875.</Citation><ArticleIdList><ArticleId IdType="pubmed">36852674</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E.. Staging of Alzheimer&#x2019;s disease-related neurofibrillary changes. Neurobiol Aging. 1995:16(3):271&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">7566337</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Del Tredici K, Rub U, de Vos RAI, Jansen Steur ENH, Braak E.. Staging of brain pathology related to sporadic Parkinson&#x2019;s disease. Neurobiol Aging. 2003:24(2):2714&#x2013;2726.</Citation><ArticleIdList><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Chance R, Macaulay IC, Chou H-J, Fletcher RB, et al.. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020:6(31):eabc5801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussiere N, Mei J, Levesque-Boissonneault C, Blais M, Carazo S, Gros-Louis F, Laforce R, De Serres G, Dupre N, Frasnelli J.. Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up. Chem Senses. 2022:47:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">35522081</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerf-Ducastel B, Murphy C.. FMRI brain activation in response to odors is reduced in primary olfactory areas of elderly subjects. Brain Res. 2003:986(1-2):39&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">12965228</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Reed RR, Lane AP.. Chronic inflammation directs an olfactory stem cell functional switch from neuroregeneration to immune defense. Cell Stem Cell. 2019:25(4):501&#x2013;513.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778045</ArticleId><ArticleId IdType="pubmed">31523027</ArticleId></ArticleIdList></Reference><Reference><Citation>Child KM, Herrick DB, Schwob JE, Holbrook EH, Jang W.. The neuroregeneratory capacity of olfactory stem cells is not limitless: Implications for aging. J Neurosci. 2018:38(31):6806&#x2013;6824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6070664</ArticleId><ArticleId IdType="pubmed">29934351</ArticleId></ArticleIdList></Reference><Reference><Citation>Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J.. Early olfactory involvement in Alzheimer&#x2019;s disease. Can J Neurol Sci. 2003:30(1):20&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">12619779</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocoros NM, Svensson E, Szepligeti SK, Vestergaard SV, Szentkuti P, Thomsen RW, Borghammer P, Sorensen HT, Henderson VW.. Long-term risk of Parkinson disease following influenza and other infections. JAMA Neurol. 2021:78:1461&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546623</ArticleId><ArticleId IdType="pubmed">34694344</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton P, Nyquist G, Murphy C, Rawson N, Joseph P, Boateng K, Silberman P, Hunter S.. Differential impact of olfactory disorders on quality of life. Bonita Springs, FL: Association for Chemoreception Sciences Annual Meeting; 2023.</Citation></Reference><Reference><Citation>Deems DA, Doty RL, Settle RG, Moore-Gillon V, Shaman P, Mester AF, Kimmelman CP, Brightman VJ, Snow JB.. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991:117(5):519&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">2021470</ArticleId></ArticleIdList></Reference><Reference><Citation>Desiato VM, Levy DA, Byun YJ, Nguyen SA, Soler ZM, Schlosser RJ.. The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis. Am J Rhinol Allergy. 2021:35(2):195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">32746612</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietz de Loos D, Lourijsen ES, Wildeman MAM, Freling NJM, Wolvers MDJ, Reitsma S, Fokkens WJ.. Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. J Allergy Clin Immunol. 2019:143(3):1207&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">30578880</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL. Treatments for smell and taste disorders: a critical review. Hand Clin Neurol. 2019:164:455&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">31604562</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL, Deems D, Stellar S.. Olfactory dysfunction in Parkinson&#x2019;s disease: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988:38:1237044.</Citation><ArticleIdList><ArticleId IdType="pubmed">3399075</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, et al.. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022:604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlay JB, Brann DH, Abi Hachem R, Jang DW, Oliva AD, Ko T, Gupta R, Wellford SA, Moseman EA, Jang SS, et al.. Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. Sci Transl Med. 2022:14(676):eadd0484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10317309</ArticleId><ArticleId IdType="pubmed">36542694</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjell AM, Westlye LT, Grydeland H, Amlien I, Espeseth T, Reinvang I, Raz N, Dale AM, Walhovd KB; Alzheimer Disease Neuroimaging Initiative. Accelerating cortical thinning: Unique to dementia or universal in aging? Cerebral cortex (New York, N.Y.: 1991). 2014:24:919&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3948495</ArticleId><ArticleId IdType="pubmed">23236213</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournel A, Iannilli E, Ferdenzi C, Werner A, Hummel T, Bensafi M.. A methodological investigation of a flexible surface MRI coil to obtain functional signals from the human olfactory bulb. J Neurosci Methods. 2020:335:108624.</Citation><ArticleIdList><ArticleId IdType="pubmed">32032715</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank C, Albertazzi A, Murphy C.. The effect of the apolipoprotein E &#x3b5;4 allele and olfactory function on odor identification networks. Brain Behavior. 2024:14(5):e3524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11069025</ArticleId><ArticleId IdType="pubmed">38702902</ArticleId></ArticleIdList></Reference><Reference><Citation>Frosolini A, Parrino D, Fabbris C, Fantin F, Inches I, Invitto S, Spinato G, Filippis C.. Magnetic resonance imaging confirmed olfactory bulb reduction in long COVID-19: literature review and case series. Brain Sci. 2022:12(4):430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9029157</ArticleId><ArticleId IdType="pubmed">35447962</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey EA, Naimi G, Hunter S, Duffy A, Silberman P, Boateng K, Schrandt S, Joseph PV, Murphy C, Trachtman J, et al.The impact of subjective sense of smell prior to olfactory dysfunction on quality of life. Bonita Springs, FL: Association for Chemoreception Sciences Annual Meeting; 2023.</Citation></Reference><Reference><Citation>Gary JB, Gallagher L, Joseph PV, Reed D, Gudis DA, Overdevest JB.. Qualitative Olfactory dysfunction and COVID-19: an evidence-based review with recommendations for the clinician. Am J Rhinol Allergy. 2023:37(1):95&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9379596</ArticleId><ArticleId IdType="pubmed">35957578</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerkin RC, Ohla K, Veldhulzen MG, Joseph PV, Kelly CE, Bakke AJ, et al.. Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms. Chem Senses. 2021:46:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799216</ArticleId><ArticleId IdType="pubmed">33367502</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez&#x2010;Aleman G, Zamponi HP, Juarez&#x2010;Aguaysol L, Kukoc G, Dominguez ME, Pini B, Padilla EG, Calv&#xf3; M, Molina&#x2010;Rangeon SB, Guerrero G, et al.. Olfactory dysfunction but not COVID&#x2010;19 severity predicts severity of cognitive sequelae following SARS&#x2010;CoV&#x2010;2 infection in Amerindian older adults. Alzheimer&#x2019;s Dementia. 2022:18(S7):e066868.</Citation></Reference><Reference><Citation>Goodspeed RB, Gent JF, Catalanotto FA.. Chemosensory dysfunction: Clinical evaluation results from a taste and smell clinic. Postgrad Med. 1987:81:251&#x2013;7, 260.</Citation><ArticleIdList><ArticleId IdType="pubmed">3809040</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, Larson EB.. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology. 1999:53(7):1480&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pubmed">10534255</ArticleId></ArticleIdList></Reference><Reference><Citation>Green BG. Surveying chemosensory perception in COVID 19. Chem Senses. 2020:45(7):509&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665321</ArticleId><ArticleId IdType="pubmed">33034353</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannum ME, Ramirez VA, Lipson SJ, Herriman RD, Toskala AK, Lin C, Joseph PV, Reed DR.. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: a systematic review and meta-analysis. Chem Senses. 2020:45(9):865&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543258</ArticleId><ArticleId IdType="pubmed">33245136</ArticleId></ArticleIdList></Reference><Reference><Citation>Harless L, Liang J.. Pharmacologic treatment for postviral olfactory dysfunction: a systematic review: Pharmacologic treatment for PVOD. Int Forum Allergy Rhinol. 2016:6(7):760&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pubmed">26879592</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris R, Davidson TM, Murphy C, Gilbert PE, Chen M.. Clinical evaluation and symptoms of chemosensory impairment: one thousand consecutive cases from the Nasal Dysfunction Clinic in San Diego. Am J Rhinol. 2006:20(1):101&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">16539304</ArticleId></ArticleIdList></Reference><Reference><Citation>Helman SN, Adler J, Jafari A, Bennett S, Vuncannon JR, Cozart AC, Wise SK, Kuruvilla ME, Levy JM.. Treatment strategies for postviral olfactory dysfunction: a systematic review. Allergy Asthma Proc. 2022:43(2):96&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8984764</ArticleId><ArticleId IdType="pubmed">35317886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman HJ, Rawal S, Li CM, Duffy VB.. New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016:17:221&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5033684</ArticleId><ArticleId IdType="pubmed">27287364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Surda P, Whitehead E, Kumar BN.. Early recovery following new onset anosmia during the COVID-19 pandemic &#x2013; an observational cohort study. J Otolaryngol Head Neck Surg. 2020:49(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196882</ArticleId><ArticleId IdType="pubmed">32366299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hura N, Xie DX, Choby GW, Schlosser RJ, Orlov CP, Seal SM, Rowan NR.. Treatment of post&#x2010;viral olfactory dysfunction: an evidence&#x2010;based review with recommendations. Int Forum Allergy Rhinol. 2020:10(9):1065&#x2013;1086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361320</ArticleId><ArticleId IdType="pubmed">32567798</ArticleId></ArticleIdList></Reference><Reference><Citation>Iravani B, Arshamian A, Ohla K, Wilson DA, Lundstr&#xf6;m J.. Non-invasive recording from the human olfactory bulb. Nat Commun. 2020:11(1):648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6994520</ArticleId><ArticleId IdType="pubmed">32005822</ArticleId></ArticleIdList></Reference><Reference><Citation>Iravani B, Arshamian A, Ravis A, Mishor E, Snitz K, Shushan S, Roth Y, Perl O, Honigstein D, Weissgross R, et al.. Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population. Chem Senses. 2020:45(6):449&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314115</ArticleId><ArticleId IdType="pubmed">32441744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari A, Holbrook EH.. Therapies for olfactory dysfunction&#x2014;an update. Curr Allergy Asthma Rep. 2022:22(3):21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785376</ArticleId><ArticleId IdType="pubmed">35072929</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MM, Larsen KD, Hom&#xf8;e AS, Simonsen AL, Arndal E, Koch A, Samuelsen GB, Nielsen XC, Todsen T, Hom&#xf8;e P.. Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results. PLoS One. 2022:17(10):e0275518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9529127</ArticleId><ArticleId IdType="pubmed">36191024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O.. Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol. 2021:28(1):28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571972</ArticleId><ArticleId IdType="pubmed">33132007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay LM. COVID-19 and olfactory dysfunction: a looming wave of dementia? J Neurophysiol. 2022:128(2):436&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9377782</ArticleId><ArticleId IdType="pubmed">35894511</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AM, Piccirillo J, Kallogjeri D, Piccirillo JF.. Efficacy of combined visual-olfactory training with patient-preferred scents as treatment for patients with COVID-19 resultant olfactory loss: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2023:149(2):141&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9857399</ArticleId><ArticleId IdType="pubmed">36580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, et al.. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020:277(8):2251&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Yang D, Zhang T, Sun J, Fu J, Li H.. Systematic review and metanalysis of olfactory and gustatory dysfunction in COVID-19. Int J Infect Dis. 2022:117:155&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8817419</ArticleId><ArticleId IdType="pubmed">35134561</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo AT, Youngentob SL, Kent PF, Schwob JE.. The aging olfactory epithelium: neurogenesis response to damage, and odorant-induced activity. Int J Dev Neurosci. 1996:14:881&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">9010732</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahadev A, Hentati F, Miller B, Bao J, Perrin A, Kallogjei D, Picirillo J.. Efficacy of gabapentin for post COVID-19 olfactory dysfunction: the GRACE randomized clinical trial. JAMA Otolayngol Head Neck Surg. 2023:149:1111&#x2013;1119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10514889</ArticleId><ArticleId IdType="pubmed">37733356</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainland JD, Barlow LA, Munger SD, Millar SE, Vergara MN, Jiang P, Schwob JE, Goldstein BJ, Boye SE, Martens JR, et al.. Identifying treatments for taste and smell disorders: gaps and opportunities. Chem Senses. 2020:45(7):493&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7545248</ArticleId><ArticleId IdType="pubmed">32556127</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride K, Blotnick B, Maargolis FL.. Does intranasal application of zinc sulfate produce anosmia in the mouse? An olfactometric and anatomical study. Chem Senses. 2003:28(8):659&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">14627534</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao X, Paez AG, Rajan S, Cao D, Liu D, Pantelyat AY, Rosenthal LI, van Zijl PCM, Bassett SS, Yousem DM, et al.. Functional activities detected in the olfactory bulb and associated olfactory regions in the human brain using T2-prepared BOLD functional MRI at 7T. Front Neurosci. 2021:15:723441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8476065</ArticleId><ArticleId IdType="pubmed">34588949</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CD, Murphy C.. Differential effects of active attention and age on event-related potentials to visual and olfactory stimuli. Internat J Psychophysiol. 2010:78(2):190&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086074</ArticleId><ArticleId IdType="pubmed">20688110</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C. Olfactory and other sensory impairments in Alzheimer disease. Nat Rev Neurol. 2019:15(1):11&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">30532084</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C, Gilmore M, Seery C, Salmon D, Lasker B.. Olfactory thresholds are associated with degree of dementia in Alzheimer&#x2019;s disease. Neurobiol Aging. 1990:11(4):465&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">2381506</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C, Hunter S, Rawson NE, Dalton PH, Trachtman J, Nyquist G, Boateng K, Silberman P, Schrandt S, Joseph P, et al.Patent centered olfactory research in the Covid Era: Age-related differences and implications for neurodegenerative disease. Bonita Springs, FL: Association for Chemoreception Sciences Annual Meeting; 2023.</Citation></Reference><Reference><Citation>Murphy C, Jernigan TL, Fennema-Notestine C.. Left hippocampal volume loss in Alzheimer&#x2019;s disease is reflected in performance on odor identification: a structural MRI study. J Int Neuropsychol Soc. 2003:9(3):459&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">12666770</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C, Morgan CD, Geisler MW, Wetter S, Covington JW, Madowitz MD, Nordin S, Polich JM.. Olfactory event-related potentials and aging: normative data. Int J Psychophysiol 2000:36(2):133&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">10742568</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM.. Prevalence of olfactory impairment in older adults. JAMA. 2002:288(18):2307&#x2013;2312.</Citation><ArticleIdList><ArticleId IdType="pubmed">12425708</ArticleId></ArticleIdList></Reference><Reference><Citation>Naimi B, Garvey EA, Hunter S, Duffy A, Silberman P, Boateng K, Schrandt S, Joseph PV, Murphy C, Trachtman J, et al.Factors associated with formal diagnosis of olfactory dysfunction in the United States. Bonita Springs, FL: Association for Chemoreception Sciences Annual Meeting; 2023.</Citation></Reference><Reference><Citation>Nordin S, Blomqvist EH, Olsson P, Stj&#xe4;rne P, Ehnhage A; NAF2S2 Study Group . Effects of smell loss on daily life and adopted coping strategies in patients with nasal polyposis with asthma. Acta Otolaryngol. 2011:131(8):826&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">21595508</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin S, Monsch AU, Murphy C.. Unawareness of smell loss in normal aging and Alzheimer&#x2019;s disease: Discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol Ser B: Psychol Sci Social Sci. 1995:50B(4):P187&#x2013;P192.</Citation><ArticleIdList><ArticleId IdType="pubmed">7606530</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, et al.. 2021 Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2012:590(7844):140&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">33137809</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva AD, Gupta R, Issa K, Abi Hachem R, Jang DW, Wellford SA, Moseman EA, Matsunami H, Goldstein BJ.. Aging-related olfactory loss is associated with olfactory stem cell transcriptional alterations in humans. J Clin Invest. 2022:132(4):e155506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8843745</ArticleId><ArticleId IdType="pubmed">34990409</ArticleId></ArticleIdList></Reference><Reference><Citation>Parma V, Ohla K, Veldhusen MG, et al.. More than smell &#x2013; COVID 19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020:45(7):609&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337664</ArticleId><ArticleId IdType="pubmed">32564071</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel ZM, Holbrook EH, Turner JH, Adappa ND, Albers MW, Altundag A, Appenzeller S, Costanzo RM, Croy I, Davis GE, et al.. International consensus statement on allergy and rhinology: Olfaction. Int Forum Allergy Rhinol. 2022:12(4):327&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">35373533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R, Cooper KW, Di Pizio A, Joseph PV, Bhutani S, Parma V.. Coronaviruses and the chemical senses: past, present, and future. Chem Senses. 2020:45(6):415&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239211</ArticleId><ArticleId IdType="pubmed">32407464</ArticleId></ArticleIdList></Reference><Reference><Citation>Philpott C, Dixon J, Boak D.. Qualitative olfactory disorders: patient experiences and self-management. Allergy Rhinol (Providence). 2021:12:21526567211004251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474348</ArticleId><ArticleId IdType="pubmed">34589267</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieniak M, Oleszkiewicz A, Avaro V, Calegari F, Hummel T.. Olfactory training&#x2014;thirteen years of research reviewed. Neurosci Biobehav Rev. 2022:141:104853.</Citation><ArticleIdList><ArticleId IdType="pubmed">36064146</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem B, Liu DT, Besser G, Sharma G, Dultinger LE, Hofer SV, Matiasczyk MM, Renner B, Mueller CA.. Long-lasting olfactory dysfunction in COVID-19 patients. Eur Arch Otorhinolaryngol. 2022:279(7):3485&#x2013;3492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8578909</ArticleId><ArticleId IdType="pubmed">34757458</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson NE, Boateng K, Schrandt S, Murphy C, Nyquist G, Trachtman J, Hunter SR, Silberman P, Joseph PV, Naimi B, et al.The patient voice matters: Outcomes from a patient engagement award from the Patient-Centered Outcomes Research Institute (Pcori). Bonita Springs, FL: Association for Chemoreception Sciences Annual Meeting; 2023.</Citation></Reference><Reference><Citation>Rawson NE, Gomez G, Cowart BJ, Kriete A, Pribitkin E, Restrepo D.. Age-associated loss of selectivity in human olfactory sensory neurons. Neurobiol Aging. 2012:33(9):1913&#x2013;1919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3299952</ArticleId><ArticleId IdType="pubmed">22074806</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, Blau H, Casiraghi E, Bergquist T, Loomba JJ, Callahan TJ, Laraway B, Antonescu C, et al.; N3C Consortium; RECOVER Consortium. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine. 2023:87:104413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraswathula A, Schlosser RJ, Rowan NR.. Reimbursement for olfactory testing: a growing need at a unique time in history. JAMA Otolaryngol Head Neck Surg. 2023:149(70):567&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11311117</ArticleId><ArticleId IdType="pubmed">37166819</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlosser RJ, Desiato VM, Storck KA, Nguyen SA, Hill JB, Washington BJ, Noonan TE, Lamira J, Mulligan JK, Rowan NR, et al.&#xa0;A community-based study on the prevalence of olfactory dysfunction. Am J Rhinol Allergy. 2020:34(5):661&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7705196</ArticleId><ArticleId IdType="pubmed">32345032</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert CR, Carmichael LL, Murphy C, Klein BEK, Klein R, Cruickshanks KJ.. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults: olfaction and the incidence of cognitive impairment. J Am Geriatr Soc. 2008:56(8):1517&#x2013;1521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2587240</ArticleId><ArticleId IdType="pubmed">18662205</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwob JE, Jang W, Holbrook EH, Lin B, Herrick DB, Peterson JN, Hewitt Coleman J.. Stem and progenitor cells of the mammalian olfactory epithelium: Taking poietic license. J Comp Neurol. 2017:525(4):1034&#x2013;1054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5805156</ArticleId><ArticleId IdType="pubmed">27560601</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuck BA, Frey S, Freiburg C, Hormann K, Zahnert T, Hummel T.. Chemosensory event-related potentials in relation to side of stimulation, age, sex and stimulus concentration. Clin Neurophysiol. 2006:117(6):1367&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pubmed">16651024</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al.. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015:12(3):e1001779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BKJ, Han R, Zhao JJ, Tan NKW, Quah ESH, Tan CJ, Chan YH, Teo NWY, Charn TC, See A, et al.. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022:378:e069503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Temmel AFP, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T.. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg. 2002:128(6):635&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pubmed">12049556</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T.. The prevalence of olfactory and gustatory dysfunction in COVID&#x2010;19 patients: a systematic review and meta&#x2010;analysis. Otolaryngol Head Neck Surg. 2020:163(1):3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32369429</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, et al.Development of a definition of postacute sequelae of SARS-CoV-2 Infection. JAMA. 2023:329(22):1934&#x2013;1946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>
The University of Oxford. OCEBM Levels of Evidence Working Group. &#x201c;The Oxford Levels of Evidence 2.&#x201d; Oxford Centre for Evidence&#x2010;Based Medicine. [accessed May 2023]. http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf.</Citation></Reference><Reference><Citation>Wang J, Eslinger PJ, Smith MB, Yang QX.. Functional magnetic resonance imaging study of human olfaction and normal aging. J Gerontol A Biol Sci Med Sci. 2005:60(4):510&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">15933393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Davis PB, Volkow ND, Berger NA, Kaelber DC, Xu R.. Association of COVID-19 with new-onset alzheimer&#x2019;s disease. J Alzheimer&#x2019;s Dis. 2022:89(2):411&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10361652</ArticleId><ArticleId IdType="pubmed">35912749</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster KE, O&#x2019;Byrne L, MacKeith S, Philpott C, Hopkins C, Burton MJ.. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2022:9(9):DC013877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9443936</ArticleId><ArticleId IdType="pubmed">36063364</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir EM, Reed DR, Pepino MY, Veldhuizen MG, Hayes JE.. Massively collaborative crowdsourced research on COVID19 and the chemical senses: insights and outcomes. Food Qual Prefer. 2022:97:104483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616712</ArticleId><ArticleId IdType="pubmed">34848930</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesson DW, Wilson DA, Nixon RA.. Editorial: Should olfactory dysfunction be used as a biomarker of Alzheimer&#x2019;s disease? Expert Rev Neurother. 2010:10:633&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3629552</ArticleId><ArticleId IdType="pubmed">20420483</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler PL, Murphy C.. Olfactory measures as predictors of conversion to mild cognitive impairment and Alzheimer&#x2019;s disease. Brain Sci. 2021:11(11):1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615615</ArticleId><ArticleId IdType="pubmed">34827390</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward MR, Amrutkar CV, Shah HC, Benedict RH, Rajakrishnan S, Doody RS, Yan L, Szigeti K.. Validation of olfactory deficit as a biomarker of Alzheimer disease. Neurol Clin Pract. 2017:7(1):5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310210</ArticleId><ArticleId IdType="pubmed">28243501</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z.. Association of treatment with Nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern Med. 2023:183:554&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan CH, Overdevest JB, Patel ZM.. Therapeutic use of steroids in non-chronic rhinosinusitis olfactory dysfunction: a systematic evidence-based review with recommendations: steroid use in non-CRS olfactory loss. Int Forum Allergy Rhinol. 2019:9(2):165&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">30472771</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P, Sun J, Wolz R, Stephenson D, Brewer J, Fox NC, Cole PE, Jack CR, Hill DLG, Schwarz AJ; Coalition Against Major Diseases and the Alzheimer's Disease Neuroimaging Initiative. Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size. Neurobiol Aging. 2014:35(4):808&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201941</ArticleId><ArticleId IdType="pubmed">24211008</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang AJ, Lee AC-Y, Chu H, Chan JF-W, Fan Z, Li C, Liu F, Chen Y, Yuan S, Poon VK-M, et al.. Severe acute respiratory syndrome coronavirus 2 infects and damages the mature and immature olfactory sensory neurons of hamsters. Clin Infect Dis. 2021:73(2):e503&#x2013;e512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454453</ArticleId><ArticleId IdType="pubmed">32667973</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>